Click for best price
Liver Cancer Diagnostics Market Size, Share 2023
The global Liver Cancer Diagnostics market was valued at US$ 11,725 million in 2022 and is projected to reach US$ 25,980 million by 2029, at a CAGR of 8.24% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Liver Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Diagnostics. This report contains market size and forecasts of Liver Cancer Diagnostics in global, including the following market information:
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biopsy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Liver Cancer Diagnostics include Abbott Laboratories, BD, Roche Holding AG, Fujifilm Healthcare, Hologic, Illumina, Philips, Oncimmune and Qiagen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Liver Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liver Cancer Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Liver Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
- Biopsy
- Endoscopy
- Laboratory Tests
- Imaging
- Others
Global Liver Cancer Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Liver Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Global Liver Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Liver Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Liver Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Liver Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- BD
- Roche Holding AG
- Fujifilm Healthcare
- Hologic
- Illumina
- Philips
- Oncimmune
- Qiagen
- Siemens Healthineers
- Sirtex Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liver Cancer Diagnostics, market overview.
Chapter 2: Global Liver Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Liver Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liver Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Liver Cancer Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liver Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liver Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liver Cancer Diagnostics Overall Market Size
2.1 Global Liver Cancer Diagnostics Market Size: 2022 VS 2030
2.2 Global Liver Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liver Cancer Diagnostics Players in Global Market
3.2 Top Global Liver Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Liver Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Liver Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Liver Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liver Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Liver Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Liver Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Liver Cancer Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Biopsy
4.1.3 Endoscopy
4.1.4 Laboratory Tests
4.1.5 Imaging
4.1.6 Others
4.2 By Type - Global Liver Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Liver Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Liver Cancer Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Liver Cancer Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liver Cancer Diagnostics Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Laboratory
5.2 By Application - Global Liver Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Liver Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Liver Cancer Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Liver Cancer Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Liver Cancer Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Liver Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Liver Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Liver Cancer Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Liver Cancer Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Liver Cancer Diagnostics Revenue, 2018-2030
6.3.2 US Liver Cancer Diagnostics Market Size, 2018-2030
6.3.3 Canada Liver Cancer Diagnostics Market Size, 2018-2030
6.3.4 Mexico Liver Cancer Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Liver Cancer Diagnostics Revenue, 2018-2030
6.4.2 Germany Liver Cancer Diagnostics Market Size, 2018-2030
6.4.3 France Liver Cancer Diagnostics Market Size, 2018-2030
6.4.4 U.K. Liver Cancer Diagnostics Market Size, 2018-2030
6.4.5 Italy Liver Cancer Diagnostics Market Size, 2018-2030
6.4.6 Russia Liver Cancer Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Liver Cancer Diagnostics Market Size, 2018-2030
6.4.8 Benelux Liver Cancer Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Liver Cancer Diagnostics Revenue, 2018-2030
6.5.2 China Liver Cancer Diagnostics Market Size, 2018-2030
6.5.3 Japan Liver Cancer Diagnostics Market Size, 2018-2030
6.5.4 South Korea Liver Cancer Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Liver Cancer Diagnostics Market Size, 2018-2030
6.5.6 India Liver Cancer Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Liver Cancer Diagnostics Revenue, 2018-2030
6.6.2 Brazil Liver Cancer Diagnostics Market Size, 2018-2030
6.6.3 Argentina Liver Cancer Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liver Cancer Diagnostics Revenue, 2018-2030
6.7.2 Turkey Liver Cancer Diagnostics Market Size, 2018-2030
6.7.3 Israel Liver Cancer Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Liver Cancer Diagnostics Market Size, 2018-2030
6.7.5 UAE Liver Cancer Diagnostics Market Size, 2018-2030
7 Liver Cancer Diagnostics Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Liver Cancer Diagnostics Major Product Offerings
7.1.4 Abbott Laboratories Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 BD
7.2.1 BD Company Summary
7.2.2 BD Business Overview
7.2.3 BD Liver Cancer Diagnostics Major Product Offerings
7.2.4 BD Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 BD Key News & Latest Developments
7.3 Roche Holding AG
7.3.1 Roche Holding AG Company Summary
7.3.2 Roche Holding AG Business Overview
7.3.3 Roche Holding AG Liver Cancer Diagnostics Major Product Offerings
7.3.4 Roche Holding AG Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Roche Holding AG Key News & Latest Developments
7.4 Fujifilm Healthcare
7.4.1 Fujifilm Healthcare Company Summary
7.4.2 Fujifilm Healthcare Business Overview
7.4.3 Fujifilm Healthcare Liver Cancer Diagnostics Major Product Offerings
7.4.4 Fujifilm Healthcare Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Fujifilm Healthcare Key News & Latest Developments
7.5 Hologic
7.5.1 Hologic Company Summary
7.5.2 Hologic Business Overview
7.5.3 Hologic Liver Cancer Diagnostics Major Product Offerings
7.5.4 Hologic Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Hologic Key News & Latest Developments
7.6 Illumina
7.6.1 Illumina Company Summary
7.6.2 Illumina Business Overview
7.6.3 Illumina Liver Cancer Diagnostics Major Product Offerings
7.6.4 Illumina Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Illumina Key News & Latest Developments
7.7 Philips
7.7.1 Philips Company Summary
7.7.2 Philips Business Overview
7.7.3 Philips Liver Cancer Diagnostics Major Product Offerings
7.7.4 Philips Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Philips Key News & Latest Developments
7.8 Oncimmune
7.8.1 Oncimmune Company Summary
7.8.2 Oncimmune Business Overview
7.8.3 Oncimmune Liver Cancer Diagnostics Major Product Offerings
7.8.4 Oncimmune Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Oncimmune Key News & Latest Developments
7.9 Qiagen
7.9.1 Qiagen Company Summary
7.9.2 Qiagen Business Overview
7.9.3 Qiagen Liver Cancer Diagnostics Major Product Offerings
7.9.4 Qiagen Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Qiagen Key News & Latest Developments
7.10 Siemens Healthineers
7.10.1 Siemens Healthineers Company Summary
7.10.2 Siemens Healthineers Business Overview
7.10.3 Siemens Healthineers Liver Cancer Diagnostics Major Product Offerings
7.10.4 Siemens Healthineers Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Siemens Healthineers Key News & Latest Developments
7.11 Sirtex Medical
7.11.1 Sirtex Medical Company Summary
7.11.2 Sirtex Medical Business Overview
7.11.3 Sirtex Medical Liver Cancer Diagnostics Major Product Offerings
7.11.4 Sirtex Medical Liver Cancer Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Sirtex Medical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Liver Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Liver Cancer Diagnostics Market Drivers in Global Market
Table 3. Liver Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Liver Cancer Diagnostics in Global Market
Table 5. Top Liver Cancer Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Liver Cancer Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Liver Cancer Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Liver Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Liver Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Liver Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Liver Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Liver Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Liver Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Liver Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Liver Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Liver Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Liver Cancer Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Liver Cancer Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Liver Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Liver Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Liver Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Liver Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Liver Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Liver Cancer Diagnostics Product Offerings
Table 32. Abbott Laboratories Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. BD Company Summary
Table 35. BD Liver Cancer Diagnostics Product Offerings
Table 36. BD Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. BD Key News & Latest Developments
Table 38. Roche Holding AG Company Summary
Table 39. Roche Holding AG Liver Cancer Diagnostics Product Offerings
Table 40. Roche Holding AG Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Holding AG Key News & Latest Developments
Table 42. Fujifilm Healthcare Company Summary
Table 43. Fujifilm Healthcare Liver Cancer Diagnostics Product Offerings
Table 44. Fujifilm Healthcare Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Fujifilm Healthcare Key News & Latest Developments
Table 46. Hologic Company Summary
Table 47. Hologic Liver Cancer Diagnostics Product Offerings
Table 48. Hologic Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Hologic Key News & Latest Developments
Table 50. Illumina Company Summary
Table 51. Illumina Liver Cancer Diagnostics Product Offerings
Table 52. Illumina Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Illumina Key News & Latest Developments
Table 54. Philips Company Summary
Table 55. Philips Liver Cancer Diagnostics Product Offerings
Table 56. Philips Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Philips Key News & Latest Developments
Table 58. Oncimmune Company Summary
Table 59. Oncimmune Liver Cancer Diagnostics Product Offerings
Table 60. Oncimmune Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Oncimmune Key News & Latest Developments
Table 62. Qiagen Company Summary
Table 63. Qiagen Liver Cancer Diagnostics Product Offerings
Table 64. Qiagen Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Qiagen Key News & Latest Developments
Table 66. Siemens Healthineers Company Summary
Table 67. Siemens Healthineers Liver Cancer Diagnostics Product Offerings
Table 68. Siemens Healthineers Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Siemens Healthineers Key News & Latest Developments
Table 70. Sirtex Medical Company Summary
Table 71. Sirtex Medical Liver Cancer Diagnostics Product Offerings
Table 72. Sirtex Medical Liver Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Sirtex Medical Key News & Latest Developments
List of Figures
Figure 1. Liver Cancer Diagnostics Segment by Type in 2022
Figure 2. Liver Cancer Diagnostics Segment by Application in 2022
Figure 3. Global Liver Cancer Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liver Cancer Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Liver Cancer Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liver Cancer Diagnostics Revenue in 2022
Figure 8. By Type - Global Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Liver Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Liver Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Liver Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Liver Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Laboratories Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BD Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Holding AG Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Fujifilm Healthcare Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hologic Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Illumina Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Philips Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Oncimmune Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Qiagen Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Siemens Healthineers Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sirtex Medical Liver Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
